↓ Skip to main content

Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems

Overview of attention for article published in Frontiers in Pharmacology, February 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
70 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems
Published in
Frontiers in Pharmacology, February 2019
DOI 10.3389/fphar.2019.00046
Pubmed ID
Authors

Fabrizio Schifano, Stefania Chiappini, John Martin Corkery, Amira Guirguis

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 14%
Student > Master 9 13%
Student > Ph. D. Student 6 9%
Researcher 4 6%
Other 4 6%
Other 10 14%
Unknown 27 39%
Readers by discipline Count As %
Medicine and Dentistry 13 19%
Pharmacology, Toxicology and Pharmaceutical Science 12 17%
Nursing and Health Professions 3 4%
Agricultural and Biological Sciences 3 4%
Psychology 3 4%
Other 11 16%
Unknown 25 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2021.
All research outputs
#15,573,531
of 26,017,215 outputs
Outputs from Frontiers in Pharmacology
#4,875
of 20,004 outputs
Outputs of similar age
#238,200
of 453,826 outputs
Outputs of similar age from Frontiers in Pharmacology
#149
of 307 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,004 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,826 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 307 others from the same source and published within six weeks on either side of this one. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.